Orbitofrontal cortex function and structure in depression

Annals of the New York Academy of Sciences

Volumn 1121, Issue , 2007, Pages 499-527

  Drevets, Wayne C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Major depressive disorder; MRI; PET

Indexed keywords

BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN REGION; CATECHOLAMINERGIC SYSTEM; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; EMOTION; GABAERGIC SYSTEM; GRAY MATTER; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; ORBITAL CORTEX; PHYSIOLOGY; PREFRONTAL CORTEX; SENSITIVITY AND SPECIFICITY; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 37049029415     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1401.029     Document Type: Conference Paper

References (147)

1. WHO. 2001. The World Health Report. www.who.int. Chapters 2 and 4.
2. DREVETS, W.C. & PRICE, J.L. 2005. Neuroimaging and neuropathological studies of mood disorders. In Biology of Depression: from Novel Insights to Therapeutic Strategies, Vol. 1. J.W.M. Licinio, Ed.: 427-466. Wiley-VCH Verlag GmbH. Weinheim, Germany.
3. ONGUR, D., A.T. FERRY & J.L. PRICE. 2003. Architectonic subdivision of the human orbital and medial prefrontal cortex. J. Comp. Neurol. 460: 425-49.
4. DREVETS, W.C. & R.D. TODD. 2005. Depression, mania and related disorders. In Adult Psychiatry, 2nd ed. E. Rubin & C. Zorumski, Ed.: 91-129. Blackwell Publishing, Ltd. Oxford.
5. DREVETS, W.C. & M.L. FUREY. 2007. Emotional disorders: depression and the Brain. In New Encyclopedia of Neuroscience. L.R. Squire, Ed. Elsevier Publishing, Inc. Oxford, UK. In press.
6. MACFALL, J.R. et al. 2001. Medial orbital frontal lesions in late-onset depression. Biol. Psychiatry 49: 803-806.
7. RAJKOWSKA, G. et al. 2005. Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol. Psychiatry 58: 297-306.
8. RING, H.A. et al. 1994. Depression in Parkinson's disease: a positron emission study. Br. J. Psychiatry 165: 333-339.
9. MAYBERG, H.S. et al. 1990. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann. Neurol. 28: 57-64.
10. DREVETS, W.C., K. GADDE & K.R.R. KRISHNAN. 2004. Neuroimaging studies of depression. In The Neurobiological Foundation of Mental Illness, 2nd ed. D.S. Charney, E. Nestler, B.J. Bunney, Ed.: 461-490. Oxford University Press. New York.
11. NUGENT, A.C. et al. 2005. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30: 485-497.
12. RAJKOWSKA, G. et al. 1999. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45: 1085-1098.
13. LYOO, I.K. et al. 2004. Frontal lobe gray matter density decreases in bipolar I disorder. Biol. Psychiatry 55: 648-651.
14. TAYLOR, W.D. et al. 2007. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol. Med. 1-11 [Epub ahead of print].
15. DREVETS, W.C. et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
16. HIRAYASU, Y. et al. 1999. Subgenual cingulate cortex volume in first-episode psychosis. Am. J. Psychiatry 156: 1091-1093.
17. CORYELL, W. et al. 2005. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am. J. Psychiatry 162: 1706-1712.
18. BOTTERON, K.N. et al. 2002. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol. Psychiatry 51: 342-344.
19. ONGUR, D., W.C. DREVETS & J.L. PRICE. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 95: 13290-13295.
20. BOWEN, D.M. et al. 1989. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl. Acad. Sci. USA 86: 9504-9508.
21. DREVETS, W.C. et al. 2004. Subgenual prefrontal cortex volume decreased in healthy humans at high familial risk for mood disorders. Soc. Neurosci. Abstr. 799.19.
22. ADLER, C.M. et al. 2005. Changes in gray matter volume in patients with bipolar disorder. Biol. Psychiatry 58: 151-157.
23. MAYBERG, H.S. et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651-660.
24. NEUMEISTER, A. et al. 2004. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch. Gen. Psychiatry 61: 765-773.
25. DREVETS, W.C. et al. 1992. A functional anatomical study of unipolar depression. J. Neurosci. 12: 3628-3641.
26. DREVETS, W.C., W. BOGERS & M.E. RAICHLE. 2002. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 12: 527-544.
27. MAYBERG, H.S. et al. 1999. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156: 675-682.
28. MAGISTRETTI, P.L. 1999. Cellular mechanisms of brain imaging metabolism and their relevance to functional brain imaging. Phil. Trans. R. Soc. London Ser. B, Biol. Sci. 354: 1155-1163.
29. BAXTER, L.R. et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 46: 243-250.
30. RAJKOWSKA, G. et al. 2007. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32: 471-482.
31. BLUMBERG, H.P. et al. 2003. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch. Gen. Psychiatry 60: 601-609.
32. RAUCH, S.L. et al. 1994. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry 51: 62-70.
33. KESSLER, R.C. et al. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62: 617-627.
34. DREVETS, W. 2000. Neuroimaging studies of mood disorders. Biol. Psychiatry 48: 813-829.
35. KETTER, T.A. & W.C. DREVETS. 2002. Neuroimaging studies of bipolar depression: functional neuropathology, treatment effects, and predictors of clinical response. Clin. Neurosci. Res. 2: 182-192.
36. DREVETS, W.C. 2001. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11: 240-249.
37. DREVETS, W.C. et al. 2002. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71: 431-447.
38. DREVETS, W., E. SPITZNAGEL & M. RAICHLE. 1995. Functional anatomical differences between major depressive subtypes. J. Cereb. Blood Flow Metab. 15: S93.
39. DREVETS, W.C. & R. TODD. 2005. Depression, mania and related disorders. In Adult Psychiatry, 2nd ed. E. Rubin & C. Zorumski, Eds.: 91-129. Blackwell Publishing, Ltd. Oxford, UK.
40. MAYBERG, H.S., et al. 1992. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 42: 1791-1797.
41. MAYBERG, H.S. et al. 1997. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
42. MAYBERG, H.S. et al. 1994. Paralimbic hypoperfusion in unipolar depression. J. Nucl. Med. 35: 929-934.
43. SCHNEIDER, F. et al. 1995. Mood effects on limbic blood flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res. 61: 265-283.
44. DREVETS, W.C., J.R. SIMPSON & M.E. RAICHLE. 1995. Regional blood flow changes in response to phobic anxiety and habituation. J. Cereb. Blood Flow Metab. 15: S856.
45. MOGENSON, G.J. et al. 1993. From motivation to action: a review of dopaminergic regulation of limbic→nucelus accumbens→ventral pallidum→pedunculopontine nucleus circuitries involved in limbic motor integration. In Limbic Motor Circuits and Neuropsychiatry. P.W. Kalivas & C.D. Barnes, Eds. CRC Press. London.
46. ONGUR, D. & J.L. PRICE. 2000. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 10: 206-219.
47. ROLLS, E.T. 1995. A theory of emotion and consciousness, and its application to understanding the neural basis of emotion. In The Cognitive Neurosciences. M.S. Gazzaniga, Ed.: 1091-1106. MIT Press. Cambridge, MA.
48. TIMMS, R.J. 1977. Cortical inhibition and facilitation of the defence reaction [proceedings]. J. Physiol. 266: 98P-99P.
49. BREMNER, J.D. et al. 2003. Regional brain metabolic correlates of alphamethylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA 289: 3125-3134.
50. BREMNER, J.D., et al. 1997. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry 54: 364-374.
51. BROZOSKI, T.J. et al. 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932.
52. ROGERS, R.D. et al. 1999. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-339.
53. MAYBERG, H.S. et al. 1999. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156: 675-682.
54. GARCIA, R. et al. 1999. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402: 294-296.
55. ABERCROMBIE, H.C. et al. 1998. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 9: 3301-3307.
56. OSUCH, E. 1999. Regional cerebral metabolism unique to anxiety symptoms in affective disorder patients. Biol. Psychiatry 45:417.
57. CORCORAN, K.A. & G.J. QUIRK. 2007. Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. J. Neurosci. 27: 840-844.
58. SIERRA-MERCADO, D., JR. et al. 2006. Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. Eur. J. Neurosci. 24: 1751-1758.
59. DOUGHERTY, D.D. et al. 2004. Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Arch. Gen. Psychiatry 61: 795-804.
60. DREVETS, W.C., D. ONGUR & J.L. PRICE. 1998. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol. Psychiatry 3: 220-226, 190-191.
61. BENES, F.M., S.L. VINCENT & M. TODTENKOPF. 2001. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 50: 395-406.
62. COTTER, D. et al. 2002. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12: 386-394.
63. COTTER, D. et al. 2001. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58: 545-553.
64. HONER, W.G. et al. 1999. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91: 1247-1255.
65. URANOVA, N. et al. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55: 597-610.
66. URANOVA, N.A. et al. 2004. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 67: 269-275.
67. RAJKOWSKA, G., A. HALARIS & L.D. SELEMON. 2001. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 49: 741-752.
68. JOHNSTON-WILSON, N.L. et al. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Stanley Neuropathology Consortium. Mol. Psychiatry 5: 142-149.
69. EASTWOOD, S.L. & P.J. HARRISON. 2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry 5: 425-432.
70. ROSOKLIJA, G. et al. 2000. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch. Gen. Psychiatry 57: 349-356.
71. EASTWOOD, S.L. & P.J. HARRISON. 2001. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders: a review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res. Bull. 55: 569-578.
72. BEZCHLIBNYK, Y.B. et al. 2007. Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. J. Psychiatry Neurosci. 32: 203-210.
73. HAMIDI, M., W.C. DREVETS & J.L. PRICE. 2004. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol. Psychiatry 55: 563-569.
74. D'AMELIO, F., L.F. ENG & M.A. GIBBS. 1990. Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system. Glia 3: 335-341.
75. CHENG, J.D. & J. DE VELLIS. 2000. Oligodendrocytes as glucocorticoids target cells: functional analysis of the glycerol phosphate dehydrogenase gene. J. Neurosci. Res. 59: 436-445.
76. ALONSO, G. 2000. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 31: 219-231.
77. SHULMAN, R.G. et al. 2004. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 27: 489-495.
78. NOWAK, G., G.A. ORDWAY & I.A. PAUL. 1995. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 675: 157-164.
79. CZEH, B. et al. 2006. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31: 1616-1626.
80. MCEWEN, B.S. & A.M. MAGARINOS. 2001. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 16: S7-S19.
81. IZQUIERDO, A., C.L. WELLMAN & A. HOLMES. 2006. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 26: 5733-5738.
82. MANJI, H.K., W.C. DREVETS & D.S. CHARNEY. 2001. The cellular neurobiology of depression. Nat. Med. 7: 541-547.
83. SANTARELLI, L. et al. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
84. HADDJERI, N., P. BLIER & C. DE MONTIGNY. 1998. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1 A receptors. J. Neurosci. 18: 10150-10156.
85. KRYSTAL, J.H. et al. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7(Suppl. 1): S71-S80.
86. PAUL, I.A. & P. SKOLNICK. 2003. Glutamate and depression: clinical and preclinical studies. Ann. N.Y. Acad. Sci. 1003: 250-272.
87. STOCKMEIER, C.A. 2003. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 37: 357-373.
88. DREVETS, W.C. et al. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46: 1375-1387.
89. SARGENT, P.A. et al. 2000. Brain serotonin1 A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57: 174-180.
90. LOPEZ, J.F. et al. 1998. A.E. Bennett Research Award. Regulation of serotonin1 A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 43: 547-573.
91. MOSES-KOLKO, E.L., et al. 2007. Measurement of 5-HT(1A) receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [(11)C]WAY-100635. Synapse 61: 523-530.
92. CASPI, A. et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
93. IZQUIERDO, A. et al. 2007. Genetic modulation of cognitive flexibility and socioemotional behavior in rhesus monkeys. Proc. Natl. Acad. Sci. USA 104: 14128-14133.
94. NUTT, D.J. 2006. The role of dopamine and norepinephrine in depression and antidepressant treatment. J. Clin. Psychiatry 67(Suppl 6): 3-8.
95. WILLNER, P. 1995. Dopaminergic mechanisms in depression and mania. In Psychopharmacology: the Fourth Generation of Progress. F.E. Bloom & D.J. Kupfer, Eds.: 921-932. Raven Press. New York.
96. LAMBERT, G. et al. 2000. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch. Gen. Psychiatry 57: 787-793.
97. VEITH, R.C. et al. 1994. Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51: 411-422.
98. SANTAMARIA, J., E. TOLOSA & A. VALLES. 1986. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36: 1130-1133.
99. NESTLER, E.J. & W.A. CARLEZON, JR. 2006. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59: 1151-1159.
100. SWERDLOW, N.R. & G.F. KOOB. 1987. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-thalamic function. Behav. Brain Sci. 10: 197-245.
101. HASLER, G. et al. 2007. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 64: 193-200.
102. AMARAL, D.G. & R. INSAUSTI. 1992. Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex. Exp. Brain Res. 88: 375-88.
103. KURODA, M. & J.L. PRICE. 1991. Synaptic organization of projections from basal forebrain structures to the mediodorsal thalamic nucleus of the rat. J. Comp. Neurol. 303: 513-533.
104. BACON, S.J. et al. 1996. Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res. 720: 211-219.
105. AMARAL, D.G. & J.L. PRICE. 1984. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J. Comp. Neurol. 230: 465-496.
106. RUSSCHEN, F.T. et al. 1985. The amygdalostriatal projections in the monkey: an anterograde tracing study. Brain Res. 329: 241-257.
107. GRAYBIEL, A.M. 1990. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13: 244-254.
108. SANACORA, G. et al. 1999. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56: 1043-1047.
109. GOLD, P.W. & G.P. CHROUSOS. 2002. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7: 254-275.
110. SWAAB, D.F., A.M. BAO & P.J. LUCASSEN. 2005. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4: 141-194.
111. LOPEZ, J.F. et al. 1992. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 56: 491-501.
112. YOUNG, E.A. et al. 1993. Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch. Gen. Psychiatry 50: 395-403.
113. GOLD, P.W., W.C. DREVETS & D.S. CHARNEY. 2002. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol. Psychiatry 52: 381-385.
114. ÖNGÜR, D. & J.L. PRICE. 2000. Intrinsic and extrinsic connections of networks within the orbital and medial prefrontal cortex. Cerebral Cortex.
115. SHELINE, Y.I. et al. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50: 651-658.
116. FU, C.H. et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61: 877-889.
117. ELLIOTT, R. et al. 2002. The neural basis of mood-congruent processing biases in depression. Arch. Gen. Psychiatry 59: 597-604.
118. NEUMEISTER, A. et al. 2006. Effects of a alpha(2C)-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31: 1750-1756.
119. SIEGLE, G.J. et al. 2002. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51: 693-707.
120. THOMAS, K.M. et al. 2001. Amygdala response to fearful faces in anxious and depressed children. Arch. Gen. Psychiatry 58: 1057-1063.
121. ALTSHULER, L.L. et al. 1991. Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch. Gen. Psychiatry 48: 482-483.
122. BAUMANN, B., et al. 1999. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a post mortem study. J. Neuropsych. Clin. Neurosci. 11: 71-78.
123. ONGUR, D. & J.L. PRICE. 1997. Distribution of glucocorticoid receptors in the Macaque central nervous system. Soc. Neurosci. Abstr. 1494.
124. BOWLEY, M.P. et al. 2002. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52: 404-412.
125. EASTWOOD, S.L. & P.J. HARRISON. 2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry 5: 425-432.
126. DAVIS, M. & C. SHI. 1999. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann. N. Y. Acad. Sci. 877: 281-291.
127. LEDOUX, J. 2003. The emotional brain, fear, and the amygdala. Cell Mol. Neurobiol. 23: 727-738.
128. LIKHTIK, E. et al. 2005. Prefrontal control of the amygdala. J. Neurosci. 25: 7429-7437.
129. PEREZ-JARANAY, J.M. & F. VIVES. 1991. Electrophysiological study of the response of medial prefrontal cortex neurons to stimulation of the basolateral nucleus of the amygdala in the rat. Brain Res. 564: 97-101.
130. GARCIA, R. et al. 1999. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402: 294-296.
131. MORGAN, M.A. & J.E. LEDOUX. 1995. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav. Neurosci. 109: 681-688.
132. SULLIVAN, R.M. & A. GRATTON. 1999. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. J. Neurosci. 19: 2834-2840.
133. IZQUIERDO, A., R.K. SUDA & E.A. MURRAY. 2005. Comparison of the effects of bilateral orbital prefrontal cortex lesions and amygdala lesions on emotional responses in rhesus monkeys. J. Neurosci. 25: 8534-8542.
134. MACHADO, C.J. & J. BACHEVALIER. 2006. The impact of selective amygdala, orbital frontal cortex, or hippocampal formation lesions on established social relationships in rhesus monkeys (Macaca mulatta). Behav. Neurosci. 120: 761-786.
135. HERMAN, J.P. & W.E. CULLINAN. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20: 78-84.
136. DIORIO, D., V. VIAU & M.J. MEANEY. 1993. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 13: 3839-3847.
137. SCHULTZ, W., P. DAYAN & P.R. MONTAGUE. 1997. A neural substrate of prediction and reward. Science 275: 1593-1599.
138. SCHULTZ, W. 1997. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol. 7: 191-197.
139. RUDEBECK, P.H. et al. 2006. A role for the macaque anterior cingulate gyrus in social valuation. Science 313: 1310-1312.
140. IZQUIERDO, A., R.K. SUDA & E.A. MURRAY. 2004. Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. J. Neurosci. 24: 7540-7548.
141. GOTO, Y. & A.A. GRACE. 2005. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat. Neurosci. 8: 805-812.
142. HADLAND, K.A. et al. 2003. The effect of cingulate lesions on social behaviour and emotion. Neuropsychologia 41: 919-931.
143. DREVETS, W.C. et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
144. PRICE, J.L., S.T. CARMICHAEL & W.C. DREVETS. 1996. Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior? Prog. Brain Res. 107: 523-536.
145. TALAIRACH, J. & P. TOURNOUX. 1988. Co-Planar Stereotaxic Axis of the Human Brain. Thieme. Stuttgart, Germany.
146. KNUTSON, B. et al. 2001. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21, RC 159: 1-5.
147. WANG, H. et al. Differential BOLD response to a monetary incentive delay task in healthy versus depressed subjects. Presented at the Annual Meeting of the Organization of Human Brain Mapping, Chicago, June 10-14, 2007.